glutathione level mda mb 468 Natural product preferentially targets redox and metabolic adaptations and aberrantly active STAT3 to inhibit breast tumor growth in vivo Disclosing a metabolic signature of

Disclosing a metabolic signature of cisplatin resistance in MDA MB 231 triple negative breast cancer cells by NMR metabolomics Cancer Cell International Springer Nature Link MDA MB 468 Luciferase Reporter Cell Line AcceGen Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells Scientific Reports Breast cancer cells that preferentially metastasize to lung or bone are more glycolytic, synthesize serine at greater rates, and consume less ATP and NADPH than parent MDA MB 231 cells Cancer & Metabolism

SKU: 79129133045 · From tmdnewgeneration.cz